EP1846018
TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.12.2005EP published:
9.7.2014EP application number:
05855968.3
EPO information:
European Patent Register
Max expiry date:
28.12.2025
Title:
TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS
Timeline
Today
29.12.2005EP application
9.7.2014EP Publication
Owner
Name:
ALLERGAN, INC.Address:
2525 Dupont Drive, 92612, Irvine CA, US
Inventor
Name:
Blumenfeld, Andrew M.Address:
La Jolla, California, US
Priority
Number:
593641 PDate:
1.2.2005Country:
US
Classification
Categories:
A61K 38/48